All In Biotech

Drug Trial Radar · NCT05109312

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.

A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures

Last checked: Nov 20, 2026Latest source record: Oct 26, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Oct 12, 2021

Primary completion

Jun 2024

Study completion Jun 2024

Sponsor

Lead sponsor
Heron TherapeuticsIndustry
Sponsor type
Industry
First posted
Nov 5, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing different surgical procedures. Each parallel cohort will enroll subjects undergoing a unique surgical procedure: total shoulder arthroplasty (TSA) in Cohort 1 and abdominoplasty in Cohort 2.

Conditions

  • Analgesia

Interventions

  • Bupivacaine HydrochlorideDrug

    100 mg

  • Bupivacaine HydrochlorideDrug

    125 mg

  • HTX-011Drug

    400 mg

  • Luer lock applicatorDevice

    Applicator for instillation

  • IbuprofenDrug

    400 mg

  • AcetaminophenDrug

    1 g

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment-emergent adverse events (TEAEs).Time frame: Through Day 15

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Woodland International Research Group, LLC

    Little Rock, Arkansas

  • Gulfcoast Research Institute

    Sarasota, Florida

  • The Orthopaedic Center

    Tulsa, Oklahoma

  • First Surgical Hospital

    Bellaire, Texas

  • Legent Orthopedic Hospital

    Carrollton, Texas

  • Endeavor Clinical Trials, LLC

    San Antonio, Texas

  • JBR Clinical Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.